PTC Therapeutics Inc. buy Royal Bank of Canada
Start price
03.12.24
/
50%
€49.60
Target price
03.12.25
€59.86
Performance (%)
-15.73%
Price
15.08.25
€41.00
Summary
This prediction is currently active. The prediction for PTC Therapeutics Inc. disappoints with a performance of -15.73%. This prediction currently runs until 03.12.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | -3.302% | -3.302% |
| iShares Core DAX® | 0.648% | 1.259% |
| iShares Nasdaq 100 | -0.034% | 2.797% |
| iShares Nikkei 225® | 2.445% | 9.854% |
| iShares S&P 500 | 0.492% | 2.570% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $63.00 price target on the stock, up previously from $39.00.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.20
07.05.25
07.05.25
€51.13
07.05.26
07.05.26
15.47%
15.08.25
15.08.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.60
22.04.25
22.04.25
€56.55
22.04.26
22.04.26
-1.44%
15.08.25
15.08.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€47.40
18.02.25
18.02.25
€60.28
18.02.26
18.02.26
-11.81%
15.08.25
15.08.25